| Online-Ressource |
Verfasst von: | Vollherbst, Dominik [VerfasserIn]  |
| Lücking, H. [VerfasserIn]  |
| DuPlessis, J. [VerfasserIn]  |
| Sonnberger, M. [VerfasserIn]  |
| Maurer, C. [VerfasserIn]  |
| Kocer, N. [VerfasserIn]  |
| Killer-Oberpfalzer, M. [VerfasserIn]  |
| Rautio, R. [VerfasserIn]  |
| Valvassori, L. [VerfasserIn]  |
| Berlis, A. [VerfasserIn]  |
| Gasser, S. [VerfasserIn]  |
| Gatt, S. [VerfasserIn]  |
| Dörfler, A. [VerfasserIn]  |
| Bendszus, Martin [VerfasserIn]  |
| Möhlenbruch, Markus Alfred [VerfasserIn]  |
Titel: | The FRESH study |
Titelzusatz: | treatment of intracranial aneurysms with the new FRED X flow diverter with antithrombotic surface treatment technology - first multicenter experience in 161 patients |
Verf.angabe: | D.F. Vollherbst, H. Lücking, J. DuPlessis, M. Sonnberger, C. Maurer, N. Kocer, M. Killer-Oberpfalzer, R. Rautio, L. Valvassori, A. Berlis, S. Gasser, S. Gatt, A. Dörfler, M. Bendszus, and M.A. Möhlenbruch |
E-Jahr: | 2023 |
Jahr: | April 10, 2023 |
Umfang: | 7 S. |
Fussnoten: | Gesehen am 06.06.2023 |
Titel Quelle: | Enthalten in: American journal of neuroradiology |
Ort Quelle: | Oak Brook, Ill. : Soc., 1980 |
Jahr Quelle: | 2023 |
Band/Heft Quelle: | 44(2023), 4 vom: Apr., Seite 474-480 |
ISSN Quelle: | 1936-959X |
Abstract: | BACKGROUND AND PURPOSE: Flow diverters with antithrombotic coatings are increasingly used to improve the safety of flow diverter treatments of intracranial aneurysms. This study aimed to investigate the safety and short-term efficacy of the new FRED X flow diverter. - MATERIALS AND METHODS: Medical charts and procedural and imaging data of a consecutive series of patients with intracranial aneurysms who were treated with the FRED X at 9 international neurovascular centers were retrospectively analyzed. - RESULTS: One hundred sixty-one patients (77.6% women; mean age, 55 years) with 184 aneurysms (11.2% acutely ruptured) were included in this study. Most aneurysms were located in the anterior circulation (77.0%), most frequently at the ICA (72.7%). The FRED X was successfully implanted in all procedures. Additional coiling was performed in 29.8%. In-stent balloon angioplasty was necessary in 2.5%. The rate of major adverse events was 3.1%. Thrombotic events occurred in 7 patients (4.3%) with 4 intra- and 4 postprocedural in-stent thromboses, respectively (1 patient had both peri- and postprocedural thrombosis). Of these thrombotic events, only 2 (1.2%) led to major adverse events (ischemic strokes). Postinterventional neurologic morbidity and mortality were observed in 1.9% and 1.2%, respectively. The rate of complete aneurysm occlusion after a mean follow-up of 7.0 months was 66.0%. - CONCLUSIONS: The new FRED X is a safe and feasible device for aneurysm treatment. In this retrospective multicenter study, the rate of thrombotic complications was low, and the short-term occlusion rates are satisfactory. |
DOI: | doi:10.3174/ajnr.A7834 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.3174/ajnr.A7834 |
| Volltext: https://www.ajnr.org/content/44/4/474 |
| DOI: https://doi.org/10.3174/ajnr.A7834 |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1847476635 |
Verknüpfungen: | → Zeitschrift |
¬The¬ FRESH study / Vollherbst, Dominik [VerfasserIn]; April 10, 2023 (Online-Ressource)